Gleevec, a brand of imatinib mesylate, is used in the treatment of Chronic Myeloid Leukemia, a rare form of cancer.
Related categories 1
Imatinib mesylate. Features prescribing and reimbursement information for US residents.
Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
Imatinib ( Glivec ) - International Site
Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
Life Raft Group
Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
Features information about dosage, usage, warnings, and side effects.
Last update:November 19, 2015 at 5:24:02 UTC